Position
SYNTAX RESEARCH, INC. in Thermo Fisher Scientific Inc.
Back to the book · All holders of TMO
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark −$400.1K$579.49 → $491.51
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 4.55K | $2.64M | — | — | — | 1.6% |
| Q1 2026 | 4.98K | $2.45M | $491.51 | −$400.1K | $213.3K | 1.6% |